Trials / Completed
CompletedNCT01159015
Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers
A Multi-center, Double-masked, Randomized, Placebo-controlled, Parallel-group Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy, Normal Volunteers
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 534 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to evaluate the safety of KetoNaph ophthalmic solution in healthy adult subjects and in pediatric subjects with a history or family history of ocular allergy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KetoNaph | Ophthalmic Solution administered BID for 6 weeks |
| DRUG | Vehicle | Vehicle of KetoNaph ophthalmic solution administered bid for six weeks |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2010-09-01
- Completion
- 2010-10-01
- First posted
- 2010-07-09
- Last updated
- 2020-10-05
- Results posted
- 2020-09-14
Source: ClinicalTrials.gov record NCT01159015. Inclusion in this directory is not an endorsement.